Intellia Therapeutics Inc sell StockNews.com
Start price
11.05.24
/
50%
€22.51
Target price
11.05.25
-
Performance (%)
-67.08%
End price
12.05.25
€7.41
Summary
This prediction ended on 12.05.25 with a price of €7.41. StockNews_com correctly predicted massive losses of -67.08% for Intellia Therapeutics Inc. StockNews_com has a follow-up prediction for Intellia Therapeutics Inc where he still thinks Intellia Therapeutics Inc is a Sell. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intellia Therapeutics Inc | 6.487% | 6.487% | -31.402% |
| iShares Core DAX® | 1.732% | 4.638% | 21.634% |
| iShares Nasdaq 100 | 3.304% | 0.517% | 5.422% |
| iShares Nikkei 225® | 2.342% | 0.972% | 15.333% |
| iShares S&P 500 | 2.357% | 0.872% | 3.125% |
Comments by StockNews_com for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) was upgraded by analysts at StockNews.com to a "sell" rating.
Ratings data for NTLA provided by MarketBeat
In the thread Trading Intellia Therapeutics Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.06
08.11.25
08.11.25
-
08.11.26
08.11.26
-11.90%
23.12.25
23.12.25
Stopped prediction by StockNews_com for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€7.77
30.11.25
30.11.25
-
30.11.26
30.11.26
2.70%
23.12.25
23.12.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€15.77
09.11.24
09.11.24
-
09.11.25
09.11.25
-42.57%
10.11.25
10.11.25